Publications (original articles or review articles) published in 2011 from OUS - Section for Preventive Cardiology

17 publications found

Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ, TNT and IDEAL Investigators (2011)
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies
Circ Cardiovasc Genet, 5 (1), 51-7
DOI 10.1161/CIRCGENETICS.111.960252, PubMed 22135385

Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
Inflammation-associated graft loss in renal transplant recipients
Nephrol Dial Transplant, 26 (11), 3756-61
DOI 10.1093/ndt/gfr163, PubMed 21511816

Fagerström KO, Gilljam H, Tonstad S (2011)
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]
Lakartidningen, 108 (44), 2215-7
PubMed 22165180

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417

Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
Rosuvastatin in diabetic hemodialysis patients
J Am Soc Nephrol, 22 (7), 1335-41
DOI 10.1681/ASN.2010090987, PubMed 21566054

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2011)
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ann Med, 44 (5), 476-86
DOI 10.3109/07853890.2011.573804, PubMed 21585246

Holme I, Tonstad S (2011)
[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]
Tidsskr Nor Laegeforen, 131 (5), 456-60
DOI 10.4045/tidsskr.10.0342, PubMed 21383797

Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I (2011)
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population
Ann Med, 44 (6), 607-15
DOI 10.3109/07853890.2011.582136, PubMed 21612332

Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C (2011)
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction
Circulation, 123 (8), 887-95
DOI 10.1161/CIRCULATIONAHA.110.983510, PubMed 21321152

Jenum AK, Mørkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdøl A, Skrivarhaug T, Vårdal MH, Holme I, Yajnik CS, Birkeland KI (2011)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur J Endocrinol, 166 (2), 317-24
DOI 10.1530/EJE-11-0866, PubMed 22108914

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2011)
Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment
BMC Pediatr, 11, 47
DOI 10.1186/1471-2431-11-47, PubMed 21619652

März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators (2011)
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
Clin J Am Soc Nephrol, 6 (6), 1316-25
DOI 10.2215/CJN.09121010, PubMed 21493741

Olsson AG, Lindahl C, Holme I, Fayyad R, Faergeman O, Kastelein JJ, Tikkanen MJ, Larsen ML, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2011)
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study
Eur J Cardiovasc Prev Rehabil, 18 (2), 262-9
DOI 10.1177/1741826710389391, PubMed 21450674

Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (2011)
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
JAMA, 305 (24), 2556-64
DOI 10.1001/jama.2011.860, PubMed 21693744

Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
Atherosclerosis, 220 (1), 250-6
DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589

Svendsen M, Tonstad S (2011)
Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
Nutr J, 10, 21
DOI 10.1186/1475-2891-10-21, PubMed 21385420

Publications (original articles or review articles) published in 2011 from OUS - Section for Preventive Cardiology

17 publications found

Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ, TNT and IDEAL Investigators (2011)
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies
Circ Cardiovasc Genet, 5 (1), 51-7
DOI 10.1161/CIRCGENETICS.111.960252, PubMed 22135385

Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
Inflammation-associated graft loss in renal transplant recipients
Nephrol Dial Transplant, 26 (11), 3756-61
DOI 10.1093/ndt/gfr163, PubMed 21511816

Fagerström KO, Gilljam H, Tonstad S (2011)
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]
Lakartidningen, 108 (44), 2215-7
PubMed 22165180

Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
Int J Cardiol, 166 (1), 72-6
DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417

Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
Rosuvastatin in diabetic hemodialysis patients
J Am Soc Nephrol, 22 (7), 1335-41
DOI 10.1681/ASN.2010090987, PubMed 21566054

Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2011)
High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
Ann Med, 44 (5), 476-86
DOI 10.3109/07853890.2011.573804, PubMed 21585246

Holme I, Tonstad S (2011)
[Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]
Tidsskr Nor Laegeforen, 131 (5), 456-60
DOI 10.4045/tidsskr.10.0342, PubMed 21383797

Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I (2011)
Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population
Ann Med, 44 (6), 607-15
DOI 10.3109/07853890.2011.582136, PubMed 21612332

Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C (2011)
Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction
Circulation, 123 (8), 887-95
DOI 10.1161/CIRCULATIONAHA.110.983510, PubMed 21321152

Jenum AK, Mørkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdøl A, Skrivarhaug T, Vårdal MH, Holme I, Yajnik CS, Birkeland KI (2011)
Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
Eur J Endocrinol, 166 (2), 317-24
DOI 10.1530/EJE-11-0866, PubMed 22108914

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2011)
Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment
BMC Pediatr, 11, 47
DOI 10.1186/1471-2431-11-47, PubMed 21619652

März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators (2011)
Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
Clin J Am Soc Nephrol, 6 (6), 1316-25
DOI 10.2215/CJN.09121010, PubMed 21493741

Olsson AG, Lindahl C, Holme I, Fayyad R, Faergeman O, Kastelein JJ, Tikkanen MJ, Larsen ML, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2011)
LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study
Eur J Cardiovasc Prev Rehabil, 18 (2), 262-9
DOI 10.1177/1741826710389391, PubMed 21450674

Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (2011)
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
JAMA, 305 (24), 2556-64
DOI 10.1001/jama.2011.860, PubMed 21693744

Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
Atherosclerosis, 220 (1), 250-6
DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589

Svendsen M, Tonstad S (2011)
Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
Nutr J, 10, 21
DOI 10.1186/1475-2891-10-21, PubMed 21385420